Association between antiphospholipid antibodies and pregnancy complications in Costa Rican women
DOI:
https://doi.org/10.51481/amc.v49i2.305Keywords:
abortion, pregnancy failures , antiphospholipid antibodies , case-control study, Costa RicaAbstract
Aim: To determine the association between antiphospholipid antibodies and pregnancy failures (abortion, preclampsia, eclampsia, placental insufficiency or delivery before the 34th week of gestation) in Costa Rican women.
Materials and Methods: The present is a case-control study, the participants belong to the Obstetrics Department of the Hospital Mexico. The period of the study was from January 2002 to December 2004. The data was obtained from the discharge registry of the Hospital descriptive analysis was done followed by univariate and multivariate analysis of the main variables.
Results: The age the patients did not show difference between cases and controls. San Jose reported a higher percentage of cases with 39.9%, followed by Heredia (26.8%) and Alajuela (24.6%). An association between the antiphospholipid antibodies and pregnancy failures in women in Costa Rica was found. The number of pregnancies did not affect the abortion and other pregnancy failures. With the unvaried and multivariate analyses a strong association between the history of the previous pregnancies was determined, and a high relationship between the antiphospholipid antibodies with abortion and other pregnancy failures was also found.
Conclusion: The antiphospholipid antibodies should be taken into account during the follow-up of the pregnancy in patients with history of abortions or pregnancy failures.
Downloads
References
Roubey RA. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996; 39:1444-1454.
Campos-García MT, Guil-García M, Grana Ml, Garrido-de Ramón E. Manifestaciones clínicas y analíticas del síndrome antifosfolípido primario. Med Clin1995; 104:37-38.
Levine JS, Branch, Rauch J. The antiphospholipid syndrome. Engl J Med 2002; 346: 752-763.
Alarcón-Segovia, D, Cabral AR. The concept and classification of antiphospholipid /cofactor syndromes. Lupus 1996; 5:364-367.
Orts JA, Zúñiga A, Orera M. Actualización de síndrome antifosfolípido. Med Clin (Barc) 2003; 121:459-471.
Petri M. Epidemiology of the antiphospholipid antibody. J Autoimmun 2000; 15:145-151.
Harris E, Pierangelli SS. Revisiting the anticardiolipin test and its standardization. Lupus 2002; 11:269-275.
Ware D, Branch, Munther A, Khamashta. Antiphospholipid Syndrome: Obstetric Diagnosis, Management, and Controversies. Obstetric Gynecol 2003; 101:1333-13344.
Cervera R, Piette JC, Font J, Khamastha MA, Shoenfeld Y, Campos MT. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002; 46:1019-1027.
Erkan D, Yazici Y, Sobel R, Lockshin MD. Primary antiphopholipid syndrome: functional outcomes alter 10 years. J Rheumatol 2000; 27:2817-2821.
Chi HS. Recent advances in the diagnosis of antiphopholipid syndrome. Int J Hematol 2002; 76 (Suppl 2): 47-51.
Khamastha M.A. Hughes syndrome: Antiphospholipid syndrome. London: Springer Publishing Company, 2000.
Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74:11851190.
Muñoz-Rodríguez FJ, Reverter JC, Font J, Tassies D, Espinoza G, Cervera R. Clinical significance of acquired active protein C resistance in patients with systemic lupus erythematosus. Lupus 2002; 11: 641643.
Sebire NJ, Regan L, Rai R. Biology and pathology of the placenta in regulation to antiphospholipid antibody- associated pregnancy failure. Lupus 2002; 11:641-643.
Rothman JK. Modern epidemiology. Boston: Little, Brown & Co., 1986.
Centers for Diseases Control and Prevention. Epi Info 2002, Manual for users. Atlanta: CDC, 2002.
Hosmer DW, Lemeshow S. Applied logistic regression, textbook and solutions manual. Chichester: Willey & Sons, 1989.
Sefer G. Antiphospholipidid Syndrome. Dismounts 2003; 49:691742.
Pierangelli SS, Gharavi AE, Harris E. Testing for antiphopholipid antibodies: problems and solutions. Clin Obstet Gynecol 2001; 44:4857.
Carbone J, Sarmiento E, Segovia P, Rodríguez-Mahon M., RodríguezMolina JJ., Fernández-Cruz E. Anticuerpos antifosfolípidos y evolución a conectivopatía: estudio de seguimiento de mujeres con abortos recurrentes. Med Clin 2002; 119:681-685.
Erkan D. The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of literature and management strategies. Curr Rheumatol Rep 2002; 4:379-386
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
